在患有代谢性酸症的幼儿中出现低血糖症
Ali H Ahmad1, Kirstin Henley2, Jessica Asencio3
1Pediatric Critical Care, University of Texas MD Anderson Cancer Center, Houston, USA.
Cureus
|November 25, 2024
概括
低血糖在儿科代谢酸性症中很常见,影响28%的年轻患者. 在患有代谢性酸症的儿童中,早期识别低血糖对于有效管理和改善结果至关重要.
科学领域:
- 儿科医学 儿科医学
- 临床化学 临床化学
- 关键的护理关键的护理
背景情况:
- 儿童的代谢性酸症在严重程度和原因上有所不同.
- 幼儿的代谢储备有限,这增加了低血糖和症的风险.
- 了解与代谢性酸化相关的因素对于儿科护理至关重要.
研究的目的:
- 研究儿童代谢酸性的原因和类型.
- 为了确定相关的电解质异常和死亡率.
- 在儿科患者中探索低血糖和代谢性酸之间的关系.
主要方法:
- 对1至71个月龄的患有代谢性酸性疾病的儿童进行了回顾性审查.
- 数据收集包括人口统计和实验室值.
- 患有低血糖和没有低血糖的儿童之间的临床特征的比较.
主要成果:
- 急性胃肠炎和带脱水的吐是最常见的诊断.
- 低血糖症发生在28%的病例中,总死亡率为2%.
- 患有化症和低血糖症的儿童年龄较大,更容易吐或AGE,住院时间较短,死亡率较低.
结论:
- 低血糖是儿科代谢性酸性疾病中常见的并发症.
- 建议在患有代谢性酸症的幼儿中考虑低血糖症.
- 这一发现可以为儿科代谢性酸性疾病的初始管理协议提供信息和结构.
相关概念视频
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Oral Hypoglycemic Agents: Glinides
141
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
141
Diabetes: Symptoms, Diagnosis, and Complications
506
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
506
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Disorders of Acid-Base Balance
149
The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
149
Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145


